The cancer immunotherapy blog

17 May Eurostars Granted Project “A novel modified natural killer (NK) cell immunotherapy for the treatment of solid tumours” – MODIFY-NK

Eurostars, a European joint programme, co-funded from the national budgets of several EUREKA countries and by the European Union through Horizon 2020 has awarded, through a highly-competitive selection process, the Project “A novel modified natural killer (NK) cell immunotherapy for the treatment of solid tumours”...

Read More

19 Feb In vitro immune cell activation

We set up a specialized in vitro immune cell activation assay based on the high throughput HTRF quantitation of key cytokine (e.g. IFNg) release, to assess your candidate compounds and biologics, as single agents and/or in combination, for their immunomodulatory properties to enhance immune cell...

Read More

31 May In vitro immune cell-mediated killing

In vitro immune cell killing assay to assess your immunomodulatory candidate compounds/antibodies for their ability to enhance the killing immune response towards tumor cells. By using live cell imaging platform, our sensitive and quantitative assay based on 96-well plate co-culture of human tumor cells...

Read More